Actively Recruiting

Phase Not Applicable
Age: 25Years - 90Years
All Genders
NCT07006818

Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function

Led by University of Illinois at Chicago · Updated on 2025-12-05

50

Participants Needed

1

Research Sites

136 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Individuals with chronic stroke have long-term walking problems that limit community engagement and quality of life, lead to secondary disabilities, and increase healthcare costs and burden. These walking issues often persist despite rehabilitation. One novel target for stroke gait rehabilitation is interlimb coordination-the phase-dependent cyclical relation of the legs. Interlimb coordination is altered during walking after stroke, compromising walking stability, phase transitions, and responses to perturbation and contributing to motor compensation. It is unclear what neural pathways contribute to impaired interlimb coordination after stroke and what impact this has on walking-related outcomes. This proposal consists of two aims to address these issues, with the long-term goal of developing therapeutic interventions to improve interlimb coordination and walking after stroke. Aim 1 will identify which neural sources contribute to impaired interlimb coordination after stroke. During bilateral, cyclical recumbent stepping (analogue of walking), interlimb coordination will be assessed as relative leg phasing. During the task, transcranial magnetic stimulation and peripheral nerve stimulation will be applied to assess supraspinal, interhemispheric, spinal interneuronal, and sensory pathways. The relation of interlimb coordination with these outcomes will be assessed to determine potential contributors. Aim 2 will test the association between interlimb coordination and walking after stroke. Interlimb coordination will be quantified during split-belt treadmill walking, and associations with walking speed, endurance, mobility, independence, daily activity, quality of life, and community engagement will be tested. An additional exploratory aim will determine the effect of targeted neuromodulation on lower limb interlimb coordination. Electrical stimulation will be applied to three locations in a cross-over study: the primary motor cortex (supraspinal/interhemispheric), thoracolumbar spine (spinal interneuronal), and peripheral nerves (sensory).

CONDITIONS

Official Title

Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function

Who Can Participate

Age: 25Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 25 and 90 years
  • Experienced a monohemispheric stroke
  • Stroke occurred more than 6 months ago (chronic phase)
  • Ability to walk for at least 6 minutes at a self-selected comfortable speed
Not Eligible

You will not qualify if you...

  • Brainstem or cerebellum lesions
  • Other neurological disorders besides stroke
  • Current botox treatments for the lower limb
  • Significant cognitive or communication impairments
  • History of adverse reactions to transcranial magnetic stimulation (TMS)
  • Skull abnormalities or fractures
  • Concussion within the previous 6 months
  • Recurring unexplained headaches
  • Implanted cardiac pacemaker
  • Metal implants in the head or face
  • History of seizures or epilepsy
  • Use of medications increasing seizure risk
  • Current pregnancy
  • Skin hypersensitivity, infections, lesions, or conditions at stimulation sites
  • History of contact dermatitis, allodynia, or hyperalgesia at stimulation sites
  • Deep vein thrombosis
  • Implanted electronic, metallic, or highly conductive devices near stimulation sites without medical approval

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Illinois at Chicago

Chicago, Illinois, United States, 60612

Actively Recruiting

Loading map...

Research Team

B

Brice T Cleland, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here